Safety of mRNA BNT162b2 COVID-19 (Pfizer-BioNtech) vaccine in children aged 5–11 years: Results from an active pharmacovigilance study in central Italy

por Ripabelli, Giancarlo, Sammarco, Michela Lucia, D’Amico, Antonio, De Dona, Roberta, Iafigliola, Mariagrazia, Parente, Albino, Samprati, Nicandro, Santagata, Arturo, Adesso, Carmen, Natale, Anna, Di Palma, Michela Anna, Cannizzaro, Fabio, Romano, Roberto, Licianci, Antonietta, Tamburro, Manuela
Publicado 2022